Literature DB >> 12395327

Hypoxia is an inducer of vasodilator agents in peritoneal macrophages of cirrhotic patients.

Pilar Cejudo-Martín1, Manuel Morales-Ruiz, Josefa Ros, Miguel Navasa, Guillermo Fernández-Varo, Josep Fuster, Francisca Rivera, Vicente Arroyo, Juan Rodés, Wladimiro Jiménez.   

Abstract

The aim of the investigation was to assess whether hypoxia induces the production of endogenous vasoactive peptides in macrophages of cirrhotic patients with ascites because low tissue oxygenation is a relatively frequent event in these patients. Peritoneal macrophages were isolated from ascites, seeded on well plates, and cultured at different times under hypoxic (5% O(2)) or normoxic conditions (21% O(2)). Then, accumulation of vasoactive peptides sensitive to hypoxia including endothelin-1 (ET-1), vascular endothelial growth factor (VEGF), and adrenomedullin (ADM) was measured. Only VEGF and ADM were constitutively secreted, and hypoxia further stimulated the release of these vasodilator peptides. In concordance, increased messenger RNA (mRNA) levels of VEGF and ADM were found at culturing macrophages in hypoxia. This characteristic response was not observed in circulating monocytes of either cirrhotic patients or healthy subjects. Next the expression of the transcription factor, hypoxia inducible factor 1 (HIF-1), was analyzed. Expression of HIF-1alpha and HIF-1beta messengers and HIF-1beta protein subunit remained unchanged regardless of O(2) tension, whereas HIF-1alpha protein subunit was overexpressed under hypoxic conditions. Moreover, conditioned medium from macrophages cultured under hypoxic conditions promoted a larger nitric oxide (NO) release in endothelial cells than that of normoxic macrophages. In conclusion, these data indicate that hypoxia induces the synthesis of VEGF and ADM in macrophages of cirrhotic patients, likely through HIF-1-enhanced transcriptional activity. These data suggest that a local reduction in O(2) tension could enhance the synthesis of macrophage-derived vasodilators, thus aggravating the circulatory disturbance of these patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12395327     DOI: 10.1053/jhep.2002.36371

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  14 in total

Review 1.  Hypoxic tumor microenvironment: Implications for cancer therapy.

Authors:  Sukanya Roy; Subhashree Kumaravel; Ankith Sharma; Camille L Duran; Kayla J Bayless; Sanjukta Chakraborty
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-27

2.  Attenuation of renal ischemia and reperfusion injury by human adrenomedullin and its binding protein.

Authors:  Kavin G Shah; Derry Rajan; Asha Jacob; Rongqian Wu; Kambhampaty Krishnasastry; Jeffrey Nicastro; Ernesto P Molmenti; Gene F Coppa; Ping Wang
Journal:  J Surg Res       Date:  2010-04-24       Impact factor: 2.192

3.  Human adrenomedullin and its binding protein ameliorate sepsis-induced organ injury and mortality in jaundiced rats.

Authors:  Juntao Yang; Rongqian Wu; Mian Zhou; Ping Wang
Journal:  Peptides       Date:  2010-02-02       Impact factor: 3.750

4.  Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissues.

Authors:  Geertu Deli; Can-Hao Jin; Rong Mu; Song Yang; Yue Liang; De Chen; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

5.  Human adrenomedullin and its binding protein attenuate organ injury and reduce mortality after hepatic ischemia-reperfusion.

Authors:  Juntao Yang; Rongqian Wu; Xiaoling Qiang; Mian Zhou; Weifeng Dong; Youxin Ji; Corrado P Marini; Thanjavur S Ravikumar; Ping Wang
Journal:  Ann Surg       Date:  2009-02       Impact factor: 12.969

6.  Human vasoactive hormone adrenomedullin and its binding protein rescue experimental animals from shock.

Authors:  Rongqian Wu; Weifeng Dong; Xiaoling Qiang; Youxin Ji; Tianpen Cui; Juntao Yang; Mian Zhou; Steven Blau; Corrado P Marini; Thanjavur S Ravikumar; Ping Wang
Journal:  Peptides       Date:  2008-03-08       Impact factor: 3.750

Review 7.  Inflammation: a way to understanding the evolution of portal hypertension.

Authors:  María-Angeles Aller; Jorge-Luis Arias; Arturo Cruz; Jaime Arias
Journal:  Theor Biol Med Model       Date:  2007-11-13       Impact factor: 2.432

8.  Hepatic arterial vasodilation is independent of portal hypertension in early stages of cirrhosis.

Authors:  Miriam Moeller; Antje Thonig; Sabine Pohl; Cristina Ripoll; Alexander Zipprich
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

Review 9.  The impact of the immune system on tumor: angiogenesis and vascular remodeling.

Authors:  Christian Stockmann; Dirk Schadendorf; Ralph Klose; Iris Helfrich
Journal:  Front Oncol       Date:  2014-04-08       Impact factor: 6.244

10.  Upregulated expression of hypoxia reactive genes in peripheral blood mononuclear cells from chronic liver disease patients.

Authors:  Akifumi Kuwano; Masatake Tanaka; Hideo Suzuki; Miho Kurokawa; Koji Imoto; Shigeki Tashiro; Takeshi Goya; Motoyuki Kohjima; Masaki Kato; Yoshihiro Ogawa
Journal:  Biochem Biophys Rep       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.